ASCO offers educational resources for cancer physicians and other health care professionals inof clinical oncology. These include scientific meetings, educational conferences, professional workshops, and special symposia on issues of particular relevance and importance to oncologists and researchers. It also produced the patient information website, Cancer.Net It publishes numerous journals, books, newsletters, and online and multimedia resources; it publishes the Journal of Clinical Oncology, the Journal of OncologyPractice, and the Journal of Global Oncology, JCO Clinical Cancer Informatics, which publishes clinically relevant research based on biomedical informatics methods and processes applied to cancer-related data, information, and images, and JCO Precision Oncology, which publishes original research, reports, opinions, and reviews related to precision oncology and genomics-driven care of patients with cancer. ASCO also publishes special curricula to address the specific educational needs of cancer professionals.
Publications
Journal of Clinical Oncology
Journal of Oncology Practice
Journal of Global Oncology
JCO Clinical Cancer Informatics
JCO Precision Oncology
ASCO Connection
Initiatives
Created by members of ASCO, the Conquer Cancer Foundation of ASCO is a 501 charitable organizatio. Since the inception of its grants and awards program in 1984, Conquer Cancer has awarded more than $90 million in funding through nearly 1,500 grants and awards to researchers in 65 countries. In 2015, the foundation launched The Campaign to Conquer Cancer, a comprehensive campaign to raise $150 million to fund cancer research, support Conquer Cancer's top priorities, and bring national awareness to the Foundation. ASCO's patient information website, Cancer.Net, is supported by the Conquer Cancer Foundation of ASCO. CancerLinQ is ASCO's data platform initiative. It was created to give oncologists a robust quality monitoring system that collects and analyzes data from all patient encounters to improve quality of care. ASCO published its Value Framework in 2015 and updated it in 2016. This provides physicians and patients with a tool to assess and compare the value of different drugs in an era of skyrocking anticancer drug costs.